Back to top

Bull of the Day

Align Technology, Inc. (ALGN) reported a strong second quarter with both revenues and earnings sailing past the Zacks Consensus Estimates, on the back of its flagship product, Invisalign. Growth was boosted by increased patient visits and a growing interest among the teenage patient population.

In addition, contribution from Cadent helped Align to further penetrate the malocclusion market. The growth momentum is expected to sustain as scanner sales and opportunities in the digital dentistry and restorative markets rise.

The company's focus on the international market, especially in Europe and China, is encouraging. Rising earnings estimates and a product with great appeal and untapped potential, in the malocclusion market make us optimistic about Align. Accordingly, we upgrade the stock to Outperform.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
SIGNET JEWE… SIG 116.37 +7.72%
INSITE VISI… INSV 0.30 +7.11%
CHYRONHEGO… CHYR 2.72 +5.84%
US SILICA H… SLCA 70.72 +4.00%
MALLINCKROD… MNK 80.11 +2.32%